(Q34919733)

5 August 2017

An official American Thoracic Society Statement: pulmonary hypertension phenotypes (English)

1 reference

5 August 2017

pulmonary hypertension

1 reference

Nicholas W Morrell

12

0 references

Marc Humbert

object named as

Marc Humbert

8

0 references

John H. Newman

15

object named as

John Newman

1 reference

5 August 2017

9

Steven M Kawut

1 reference

5 August 2017

Raed A Dweik

1

1 reference

5 August 2017

Sharon Rounds

2

1 reference

5 August 2017

Serpil C Erzurum

3

1 reference

5 August 2017

Stephen Archer

4

1 reference

5 August 2017

Karen Fagan

5

1 reference

5 August 2017

Paul M Hassoun

6

1 reference

5 August 2017

Nicholas S Hill

7

1 reference

5 August 2017

Michael Krowka

10

1 reference

5 August 2017

Evangelos Michelakis

11

1 reference

5 August 2017

Kurt Stenmark

13

1 reference

5 August 2017

Rubin M Tuder

14

1 reference

5 August 2017

ATS Committee on Pulmonary Hypertension Phenotypes

16

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

5 August 2017

1 reference

5 August 2017

189

1 reference

5 August 2017

3

1 reference

5 August 2017

345-355

1 reference

Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Nitric oxide in adaptation to altitude

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Clinical features of paediatric pulmonary hypertension: a registry study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Combined pulmonary fibrosis and emphysema syndrome: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Obesity and right ventricular structure and function: the MESA-Right Ventricle Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Unrecognized glucose intolerance is common in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Updated clinical classification of pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Age-associated increases in pulmonary artery systolic pressure in the general population

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Association of the metabolic syndrome with pulmonary venous hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Insulin resistance in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension in COPD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

High levels of hyaluronan in idiopathic pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Clinical risk factors for portopulmonary hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

'Deep phenotyping': characterizing populations in the era of genomics and systems biology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension in idiopathic pulmonary fibrosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension associated with left-sided heart disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Changes in causes of death in systemic sclerosis, 1972-2002

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Alterations of cellular bioenergetics in pulmonary artery endothelial cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary arterial hypertension in France: results from a national registry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Hemodynamics and survival of patients with portopulmonary hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Abnormalities in nitric oxide and its derivatives in lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Clinical classification of pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

8 July 2018

Scleroderma epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Predictors of end stage lung disease in systemic sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pathogenesis of HIV-related pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Regression of extreme pulmonary hypertension after mitral valve surgery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Primary pulmonary hypertension in HIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT.

8 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Pulmonary hypertension and the search for the selective pulmonary vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Prevalence and Correlates of Septal Delayed Contrast Enhancement in Patients With Pulmonary Hypertension†

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Multimodality comparison of quantitative volumetric analysis of the right ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Portopulmonary hypertension: Results from a 10-year screening algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Portopulmonary hypertension: a report from the US-based REVEAL Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Unexplained pulmonary hypertension in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201311-1954ST

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291177

EFFECTS OF MITRAL-VALVE REPLACEMENT ON THE PULMONARY VASCULAR DYNAMICS OF PATIENTS WITH PULMONARY HYPERTENSION

26 October 2018

1 reference

12 December 2020

AASLD practice guidelines: Evaluation of the patient for liver transplantation

1 reference

12 December 2020

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

1 reference

12 December 2020

Right coronary artery flow impairment in patients with pulmonary hypertension

1 reference

12 December 2020

Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients

1 reference

12 December 2020

Portopulmonary Hypertension

1 reference

12 December 2020

Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension

1 reference

12 December 2020

Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA

1 reference

12 December 2020

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Right heart function in scleroderma: insights from myocardial Doppler tissue imaging

1 reference

12 December 2020

Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension

1 reference

12 December 2020

Right heart function and scleroderma: insights from tricuspid annular plane systolic excursion

1 reference

12 December 2020

Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases

1 reference

12 December 2020

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

12 December 2020

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

1 reference

12 December 2020

Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study

1 reference

12 December 2020

Chronic thromboembolic pulmonary hypertension

1 reference

12 December 2020

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Primary Pulmonary Hypertension in the Elderly

1 reference

12 December 2020

10.1164/RCCM.201311-1954ST

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference